Expanding the Universe of Targets
NeoSplice™ is an AI-powered, therapeutics-enabling target discovery platform that can detect orders of magnitude more targets than traditional drug discovery.
SCROLL
NeoSplice™ is an AI-powered, therapeutics-enabling target discovery platform that can detect orders of magnitude more targets than traditional drug discovery.
NeoSplice™ is an AI-powered, therapeutics-enabling target discovery platform that can detect orders of magnitude more targets than traditional drug discovery. By harnessing advanced computational and lab approaches, we are expanding the landscape of druggable targets and unlocking new therapeutic possibilities. Our platform identifies novel targets that conventional methods miss—opening pathways to treatments for diseases with significant unmet medical needs.
We are on a mission to fundamentally transform how therapeutic targets are discovered. We believe that target discovery has become the real bottleneck in precision medicine. NeoSplice Therapeutics is building the foundation for the next generation of precision medicines.
NeoSplice Therapeutics is selected to the prestigious Endless Frontiers Labs program.
View on LinkedIn →NeoSplice Therapeutics was selected as a finalist for the Servier Golden Ticket Contest.
View on LinkedIn →NeoSplice Therapeutics presents its poster at the American Association for Cancer Research conference in San Diego.
View on LinkedIn →NeoSplice Therapeutics is selected to the American Cancer Society BrightEdge program.
View on LinkedIn →NeoSplice Therapeutics was selected as one of the top 7 teams for the Alnylam BioVenture Competition.
View on LinkedIn →
NeoSplice provides biotechnology research and development services in the field of therapeutic target discovery, including scientific research using AI and experimental methods in biology. We are actively looking for partnerships with Pharma and Biotech.